Multiple Sclerosis Clinical Trial
Official title:
Effect of Transorbital Electrical STIMulation of Optic Nerve on Remyelination After an Acute Optic Neuritis
In light of experimental models showing that neuronal electrical activity is crucial for the
remyelination process, we hypothesize that maintenance of electrical axonal activity in the
early stages of optic neuritis may promote myelin repair, limiting thereby axonal
degeneration.
In humans, electrical stimulation of the optic nerve has been tested mainly in ischemic
neuropathy and retinitis pigmentosa, which are both associated with severe axonal/retinal
pathology and poor visual prognosis. In contrast, the inflammation of the optic nerve in
optic neuritis is generally transient, with less severe axonal damage at the acute phase,
which would allow for better efficacy of electrical stimulation as a strategy to promote
remyelination and neuroprotection.In light of experimental models showing that neuronal
electrical activity is crucial for the remyelination process, we hypothesize that maintenance
of electrical axonal activity in the early stages of optic neuritis may promote myelin
repair, limiting thereby axonal degeneration.
In humans, electrical stimulation of the optic nerve has been tested mainly in ischemic
neuropathy and retinitis pigmentosa, which are both associated with severe axonal/retinal
pathology and poor visual prognosis. In contrast, the inflammation of the optic nerve in
optic neuritis is generally transient, with less severe axonal damage at the acute phase,
which would allow for better efficacy of electrical stimulation as a strategy to promote
remyelination and neuroprotection.
This is a randomized, controlled, prospective, interventional, blinded trial which aims to
evaluate the safety and efficacy of transorbital electrical nerve stimulation on
remyelination and neuroprotection after an acute episode of retrobulbar optic neuritis in
patients with multiple sclerosis (MS).
Expected Explorations: The study is composed of 14 visits: a screening/inclusion visit with
neurological and ophthalmological evaluation, electrophysiology, MRI and
Magnetoencephalography (MEG), 10 transorbital electrical stimulation or sham stimulation
visits and finally 3 follow-up visits and evaluations (neurological and ophthalmological).
Patient's participation will last 49 weeks (inclusion visit and 48 weeks of follow-up).
Participation of healthy volunteers will last one day.
MS patients diagnosed with an optic neuritis will be randomized either in the active arm
(transorbital electrical stimulation of the optic nerve - 10 sessions during 2 consecutive
weeks) or in the placebo arm (sham stimulation - 10 sessions during 2 consecutive weeks)
Expected benefits: Electrical stimulation of the optic nerve after an acute episode of
retrobulbar optic neuritis may promote remyelination in the optic nerve and a better
long-term visual outcome.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT02845635 -
MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
|